Clinical Trials
533
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (372 trials with phase data)• Click on a phase to view related trials
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
- Conditions
- Heart Failure - NYHA II - IV
- First Posted Date
- 2025-07-17
- Last Posted Date
- 2025-07-17
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 850
- Registration Number
- NCT07069738
Safety and Effectiveness of Orbera365™ Intragastric Balloon System
- Conditions
- Obesity
- First Posted Date
- 2025-07-14
- Last Posted Date
- 2025-07-14
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 200
- Registration Number
- NCT07062094
Endo-SPONGE for Treatment of Anastomotic or Hartmann's Stump Leakages in Lower Pelvic Area
- Conditions
- Anastomotic LeaksHartmanns Stump Leakage
- First Posted Date
- 2025-06-25
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 66
- Registration Number
- NCT07035431
- Locations
- 🇺🇸
Barnes Jewish Hospital, Saint Louis, Missouri, United States
🇺🇸Mount Sinai, New York, New York, United States
🇺🇸New York Presbyterian / Columbia University Irving Medical Center, New York, New York, United States
Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric Bypass
- Conditions
- Weight RegainWeight Loss
- First Posted Date
- 2025-06-11
- Last Posted Date
- 2025-06-11
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 108
- Registration Number
- NCT07015424
- Locations
- 🇺🇸
University of South Florida, Tampa, Florida, United States
Stone and Laser Therapies Post-Market Study (SALT)
- Conditions
- Benign Prostate Hypertrophy(BPH)Renal CalculiUreteral Stones, Kidney StonesUrinary Tract ProcedureCalculi, Urinary
- First Posted Date
- 2025-05-21
- Last Posted Date
- 2025-07-24
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 238
- Registration Number
- NCT06982235
- Locations
- 🇺🇸
University of Miami Hospital, Miami, Florida, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 101
- Next
News
VIVA24: Late-Breaking Trials Highlight Advances in Vascular Intervention
The PROMISE II trial demonstrates sustained limb salvage and wound healing at 2 years using the LimFlow System for no-option CLTI patients.
VIVA24: Late-Breaking Trials Highlight Advances in Peripheral Artery Disease Treatment
The PROMISE II trial demonstrates sustained limb salvage and wound healing at two years using the LimFlow System for no-option CLTI patients.
VIVA24: Novel Therapies Show Promise in Vascular Disease Treatment
• The Esprit BTK scaffold demonstrated superior long-term outcomes in treating chronic limb-threatening ischemia compared to percutaneous transluminal angioplasty. • Shockwave Javelin Peripheral IVL catheter met efficacy and safety goals, significantly reducing stenosis in severely calcified lesions. • TCAR using the ENROUTE system proves safe and effective for carotid stenosis in standard-surgical-risk patients, with low stroke and cranial nerve injury rates.
Senseonics' Eversense 365 CGM System Receives FDA Clearance for One-Year Use
Senseonics and Ascensia Diabetes Care secured FDA clearance for Eversense 365, a next-generation continuous glucose monitoring (CGM) system, for adults with type 1 and type 2 diabetes.